$12.71
2.98% yesterday
NYSE, May 13, 10:10 pm CET
ISIN
US05350V1061
Symbol
AVNS

Avanos Medical, Inc. Stock price

$12.71
+0.30 2.42% 1M
-6.78 34.79% 6M
-3.21 20.16% YTD
-7.17 36.07% 1Y
-13.66 51.80% 3Y
-13.07 50.70% 5Y
-31.29 71.11% 10Y
NYSE, Closing price Tue, May 13 2025
-0.39 2.98%
ISIN
US05350V1061
Symbol
AVNS
Sector

Key metrics

Market capitalization $587.76m
Enterprise Value $631.66m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 5.54
EV/Sales (TTM) EV/Sales 0.92
P/S ratio (TTM) P/S ratio 0.85
P/B ratio (TTM) P/B ratio 0.70
Revenue growth (TTM) Revenue growth 1.34%
Revenue (TTM) Revenue $689.20m
EBIT (operating result TTM) EBIT $52.60m
Free Cash Flow (TTM) Free Cash Flow $114.00m
Cash position $97.00m
EPS (TTM) EPS $-8.36
P/S forward 0.87
EV/Sales forward 0.94
Short interest 3.47%
Show more

Is Avanos Medical, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,793 stocks worldwide.

Avanos Medical, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Avanos Medical, Inc. forecast:

2x Hold
100%

Analyst Opinions

2 Analysts have issued a Avanos Medical, Inc. forecast:

Hold
100%

Financial data from Avanos Medical, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
689 689
1% 1%
100%
- Direct Costs 312 312
5% 5%
45%
378 378
1% 1%
55%
- Selling and Administrative Expenses 257 257
5% 5%
37%
- Research and Development Expense 25 25
8% 8%
4%
96 96
13% 13%
14%
- Depreciation and Amortization 44 44
1% 1%
6%
EBIT (Operating Income) EBIT 53 53
21% 21%
8%
Net Profit -385 -385
518% 518%
-56%

In millions USD.

Don't miss a Thing! We will send you all news about Avanos Medical, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Avanos Medical, Inc. Stock News

Neutral
Seeking Alpha
8 days ago
Avanos Medical, Inc. (NYSE:AVNS ) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy and Corporate Development Dave Pacitti - Chief Executive Officer Jason Pickett - Interim Chief Financial Officer and Treasurer Conference Call Participants Rick Wise - Stifel Daniel Stauder - Citizens JMP Operator Good morning, ladies and gent...
Neutral
PRNewsWire
8 days ago
ALPHARETTA, Ga. , May 6, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2025 financial results.
Neutral
PRNewsWire
16 days ago
ALPHARETTA, Ga. , April 28, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2025 on Tuesday, May 6 at 9 a.m.
More Avanos Medical, Inc. News

Company Profile

Avanos Medical, Inc. is a medical technology company, which focuses on delivering clinically medical device solutions to improve patients' quality of life. Its portfolio of innovative product offerings focused on respiratory and digestive health, along with surgical and interventional pain management to improve patient outcomes and reduce the cost of care. Its brands include ON-Q, Coolife, Microcuff, MIC-Key, Quilbloc and Home pump. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.

Head office United States
CEO David Pacitti
Employees 2,227
Founded 2014
Website www.avanos.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today